MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer

Cancer Letters

Volumn 356, Issue 2, 2015, Pages 962-970

  Jiang, Jianxin ^a   Li, Zhu ^a   Yu, Chao ^a   Chen, Meiyuan ^a   Tian, Se ^a   Sun, Chengyi ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cells; MiR 1181; Pancreatic cancer; SOX2; STAT3

Indexed keywords

MICRORNA; MICRORNA 1181; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; MESSENGER RNA; SMALL INTERFERING RNA; SOX2 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER PATIENT; CANCER STEM CELL; CARCINOGENICITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STAGING; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; NUDE MOUSE; PANCREAS; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PANCREAS; PANCREATIC NEOPLASMS; PHENOTYPE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR; SURVIVAL RATE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84919499625     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.007     Document Type: Article

References (42)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin 2013, 63:11-30.
2. Hidalgo M. Pancreatic cancer. N. Engl. J. Med 2010, 362:1605-1617.
3. Schultz N.A., Dehlendorff C., Jensen B.V., Bjerregaard J.K., Nielsen K.R., Bojesen S.E., et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 2014, 311:392-404.
4. Gerger A., Zhang W., Yang D., Bohanes P., Ning Y., Winder T., et al. Common cancer stem cell gene variants predict colon cancer recurrence. Clin. Cancer Res 2011, 17:6934-6943.
5. Sergeant G., Vankelecom H., Gremeaux L., Topal B. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat. Rev. Clin. Oncol 2009, 6:580-586.
6. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
7. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
8. Lee C.J., Dosch J., Simeone D.M. Pancreatic cancer stem cells. J. Clin. Oncol 2008, 26:2806-2812.
9. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
10. Welsch T., Keleg S., Bergmann F., Degrate L., Bauer S., Schmidt J. Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Clin. Exp. Metastasis 2009, 26:701-711.
11. Boumahdi S., Driessens G., Lapouge G., Rorive S., Nassar D., Le Mercier M., et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 2014, 511(7508):246-250.
12. Favaro R., Appolloni I., Pellegatta S., Sanga A.B., Pagella P., Gambini E., et al. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res 2014, 74:1833-1844.
13. Herreros-Villanueva M., Zhang J.S., Koenig A., Abel E.V., Smyrk T.C., Bamlet W.R., et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2013, 2. e61.
14. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
15. Leis O., Eguiara A., Lopez-Arribillaga E., Alberdi M.J., Hernandez-Garcia S., Elorriaga K., et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 2012, 31:1354-1365.
16. Rudin C.M., Durinck S., Stawiski E.W., Poirier J.T., Modrusan Z., Shames D.S., et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet 2012, 44:1111-1116.
17. Sanada Y., Yoshida K., Ohara M., Oeda M., Konishi K., Tsutani Y. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 2006, 32:164-170.
18. Zhao M., Amiel S.A., Christie M.R., Muiesan P., Srinivasan P., Littlejohn W., et al. Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J. Endocrinol 2007, 195:407-414.
19. Liu K., Jiang M., Lu Y., Chen H., Sun J., Wu S., et al. Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell 2013, 12:304-315.
20. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
21. Lee J.Y., Hennighausen L. The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function. Biochem. Biophys. Res. Commun 2005, 334:764-768.
22. Fukuda A., Wang S.C., Morris J.P., Folias A.E., Liou A., Kim G.E., et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011, 19:441-455.
23. Scholz A., Heinze S., Detjen K.M., Peters M., Welzel M., Hauff P., et al. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003, 125:891-905.
24. Wei D., Le X., Zheng L., Wang L., Frey J.A., Gao A.C., et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003, 22:319-329.
25. Corcoran R.B., Contino G., Deshpande V., Tzatsos A., Conrad C., Benes C.H., et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011, 71:5020-5029.
26. Denley S.M., Jamieson N.B., McCall P., Oien K.A., Morton J.P., Carter C.R., et al. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J. Gastrointest. Surg 2013, 17:887-898.
27. Panni R.Z., Sanford D.E., Belt B.A., Mitchem J.B., Worley L.A., Goetz B.D., et al. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunol. Immunother 2014, 63:513-528.
28. Sherry M.M., Reeves A., Wu J.K., Cochran B.H. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 2009, 27:2383-2392.
29. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med 2011, 17:211-215.
30. Yu C.C., Tsai L.L., Wang M.L., Yu C.H., Lo W.L., Chang Y.C., et al. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 2013, 73:3425-3440.
31. Liu L., Chen K., Wu J., Shi L., Hu B., Cheng S., et al. Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas. Clin. Cancer Res 2013, 19:3429-3438.
32. Oda D., Savard C.E., Nguyen T.D., Swenson E.R., Lee S.P. Culture of human main pancreatic duct epithelial cells. In Vitro Cell. Dev. Biol. Anim 1998, 34:211-216.
33. Yamaguchi H., Kojima T., Ito T., Kimura Y., Imamura M., Son S., et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am. J. Pathol 2010, 177:698-712.
34. de Sousa E.M.F., Colak S., Buikhuisen J., Koster J., Cameron K., de Jong J.H., et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011, 9:476-485.
35. Simeone D.M. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Clin. Cancer Res 2008, 14:5646-5648.
36. Mimeault M., Johansson S.L., Senapati S., Momi N., Chakraborty S., Batra S.K. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Lett 2010, 295:69-84.
37. Moriyama T., Ohuchida K., Mizumoto K., Cui L., Ikenaga N., Sato N., et al. Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells. Cancer 2010, 116:3357-3368.
38. Lesina M., Kurkowski M.U., Ludes K., Rose-John S., Treiber M., Kloppel G., et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011, 19:456-469.
39. Wang H., Lathia J.D., Wu Q., Wang J., Li Z., Heddleston J.M., et al. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 2009, 27:2393-2404.
40. Venkatasubbarao K., Peterson L., Zhao S., Hill P., Cao L., Zhou Q., et al. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer. Mol. Cancer 2013, 12:104.
41. Waldman S.A., Terzic A. Translating microRNA discovery into clinical biomarkers in cancer. JAMA 2007, 297:1923-1925.
42. Nam E.J., Lee M., Yim G.W., Kim J.H., Kim S., Kim S.W., et al. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. BMC Med. Genomics 2012, 5:18.